The role of radiation therapy in patients with primary and metastatic liver tumours

Technical advances in tumour imaging, radiation therapy planning and patient's motion management have made possible the evolving role of conformal radiotherapy (CRT) and stereotactic irradiation (STIR) in the treatment of patients with primary and metastatic liver tumours. A variety of doses an...

Full description

Saved in:
Bibliographic Details
Published in:Contemporary oncology (Poznań, Poland) Poland), 2008-10, Vol.12 (6), p.272
Main Authors: Glinski, Bogdan, Mucha-Malecka, Anna, Jakubowicz, Jerzy, Fraczek-Blachut, Beata
Format: Article
Language:eng ; pol
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 6
container_start_page 272
container_title Contemporary oncology (Poznań, Poland)
container_volume 12
creator Glinski, Bogdan
Mucha-Malecka, Anna
Jakubowicz, Jerzy
Fraczek-Blachut, Beata
description Technical advances in tumour imaging, radiation therapy planning and patient's motion management have made possible the evolving role of conformal radiotherapy (CRT) and stereotactic irradiation (STIR) in the treatment of patients with primary and metastatic liver tumours. A variety of doses and fractionation systems have been used in CRT/STIR in combination with other therapies, mainly with transarterial hepatic embolization (TAHE). Outcomes following CRT/STIR alone or CRT/STIR with TAHE appear better than outcomes following similar historical controls or TAHE alone; however, randomized trials are needed to confirm this observation. Excellent local tumour control rates and a promising survival rate with low toxicity are seen using CRT/STIR. The best results are obtained in patients who can be treated with high level doses. In conclusion, radiation therapy of patients with primary and metastatic liver tumours is well tolerated and gives the good results compared to other treatment schedules.
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1237574428</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2839815241</sourcerecordid><originalsourceid>FETCH-LOGICAL-p113t-9e80b2dc346853091ad259c2e15d15ad2d5c218a583046a4b99b25f29ddb0da43</originalsourceid><addsrcrecordid>eNotT8tqwzAQFKWFhjT_sNCzQU9bOobQFwR6aHoOa0vGCrblSnJL_r6C9jSzMzCzc0M2TJumkoKa28Il1xVXvL4nu5R8SylrtKqF2JCP0-AghtFB6CGi9Zh9mCEPLuJyBT_DUhQ35wQ_Pg-wRD9hvALOFiaXMeVidzD6bxchr1NYY3ogdz2Oye3-cUs-n59Oh9fq-P7ydtgfq4UxkSvjNG257YSstSqPMrRcmY47pixT5bCq40yj0oLKGmVrTMtVz421LbUoxZY8_uUuMXytLuXzpdTPpfLMuGhUI8tu8QthEk5Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1237574428</pqid></control><display><type>article</type><title>The role of radiation therapy in patients with primary and metastatic liver tumours</title><source>ProQuest - Publicly Available Content Database</source><creator>Glinski, Bogdan ; Mucha-Malecka, Anna ; Jakubowicz, Jerzy ; Fraczek-Blachut, Beata</creator><creatorcontrib>Glinski, Bogdan ; Mucha-Malecka, Anna ; Jakubowicz, Jerzy ; Fraczek-Blachut, Beata</creatorcontrib><description>Technical advances in tumour imaging, radiation therapy planning and patient's motion management have made possible the evolving role of conformal radiotherapy (CRT) and stereotactic irradiation (STIR) in the treatment of patients with primary and metastatic liver tumours. A variety of doses and fractionation systems have been used in CRT/STIR in combination with other therapies, mainly with transarterial hepatic embolization (TAHE). Outcomes following CRT/STIR alone or CRT/STIR with TAHE appear better than outcomes following similar historical controls or TAHE alone; however, randomized trials are needed to confirm this observation. Excellent local tumour control rates and a promising survival rate with low toxicity are seen using CRT/STIR. The best results are obtained in patients who can be treated with high level doses. In conclusion, radiation therapy of patients with primary and metastatic liver tumours is well tolerated and gives the good results compared to other treatment schedules.</description><identifier>ISSN: 1428-2526</identifier><identifier>EISSN: 1897-4309</identifier><language>eng ; pol</language><publisher>Poznan: Termedia Publishing House</publisher><ispartof>Contemporary oncology (Poznań, Poland), 2008-10, Vol.12 (6), p.272</ispartof><rights>Copyright Termedia Publishing House 2008</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1237574428?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25753,37012,44590</link.rule.ids></links><search><creatorcontrib>Glinski, Bogdan</creatorcontrib><creatorcontrib>Mucha-Malecka, Anna</creatorcontrib><creatorcontrib>Jakubowicz, Jerzy</creatorcontrib><creatorcontrib>Fraczek-Blachut, Beata</creatorcontrib><title>The role of radiation therapy in patients with primary and metastatic liver tumours</title><title>Contemporary oncology (Poznań, Poland)</title><description>Technical advances in tumour imaging, radiation therapy planning and patient's motion management have made possible the evolving role of conformal radiotherapy (CRT) and stereotactic irradiation (STIR) in the treatment of patients with primary and metastatic liver tumours. A variety of doses and fractionation systems have been used in CRT/STIR in combination with other therapies, mainly with transarterial hepatic embolization (TAHE). Outcomes following CRT/STIR alone or CRT/STIR with TAHE appear better than outcomes following similar historical controls or TAHE alone; however, randomized trials are needed to confirm this observation. Excellent local tumour control rates and a promising survival rate with low toxicity are seen using CRT/STIR. The best results are obtained in patients who can be treated with high level doses. In conclusion, radiation therapy of patients with primary and metastatic liver tumours is well tolerated and gives the good results compared to other treatment schedules.</description><issn>1428-2526</issn><issn>1897-4309</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNotT8tqwzAQFKWFhjT_sNCzQU9bOobQFwR6aHoOa0vGCrblSnJL_r6C9jSzMzCzc0M2TJumkoKa28Il1xVXvL4nu5R8SylrtKqF2JCP0-AghtFB6CGi9Zh9mCEPLuJyBT_DUhQ35wQ_Pg-wRD9hvALOFiaXMeVidzD6bxchr1NYY3ogdz2Oye3-cUs-n59Oh9fq-P7ydtgfq4UxkSvjNG257YSstSqPMrRcmY47pixT5bCq40yj0oLKGmVrTMtVz421LbUoxZY8_uUuMXytLuXzpdTPpfLMuGhUI8tu8QthEk5Y</recordid><startdate>20081001</startdate><enddate>20081001</enddate><creator>Glinski, Bogdan</creator><creator>Mucha-Malecka, Anna</creator><creator>Jakubowicz, Jerzy</creator><creator>Fraczek-Blachut, Beata</creator><general>Termedia Publishing House</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BYOGL</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>20081001</creationdate><title>The role of radiation therapy in patients with primary and metastatic liver tumours</title><author>Glinski, Bogdan ; Mucha-Malecka, Anna ; Jakubowicz, Jerzy ; Fraczek-Blachut, Beata</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p113t-9e80b2dc346853091ad259c2e15d15ad2d5c218a583046a4b99b25f29ddb0da43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; pol</language><creationdate>2008</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Glinski, Bogdan</creatorcontrib><creatorcontrib>Mucha-Malecka, Anna</creatorcontrib><creatorcontrib>Jakubowicz, Jerzy</creatorcontrib><creatorcontrib>Fraczek-Blachut, Beata</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>East Europe, Central Europe Database</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Contemporary oncology (Poznań, Poland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Glinski, Bogdan</au><au>Mucha-Malecka, Anna</au><au>Jakubowicz, Jerzy</au><au>Fraczek-Blachut, Beata</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of radiation therapy in patients with primary and metastatic liver tumours</atitle><jtitle>Contemporary oncology (Poznań, Poland)</jtitle><date>2008-10-01</date><risdate>2008</risdate><volume>12</volume><issue>6</issue><spage>272</spage><pages>272-</pages><issn>1428-2526</issn><eissn>1897-4309</eissn><abstract>Technical advances in tumour imaging, radiation therapy planning and patient's motion management have made possible the evolving role of conformal radiotherapy (CRT) and stereotactic irradiation (STIR) in the treatment of patients with primary and metastatic liver tumours. A variety of doses and fractionation systems have been used in CRT/STIR in combination with other therapies, mainly with transarterial hepatic embolization (TAHE). Outcomes following CRT/STIR alone or CRT/STIR with TAHE appear better than outcomes following similar historical controls or TAHE alone; however, randomized trials are needed to confirm this observation. Excellent local tumour control rates and a promising survival rate with low toxicity are seen using CRT/STIR. The best results are obtained in patients who can be treated with high level doses. In conclusion, radiation therapy of patients with primary and metastatic liver tumours is well tolerated and gives the good results compared to other treatment schedules.</abstract><cop>Poznan</cop><pub>Termedia Publishing House</pub><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1428-2526
ispartof Contemporary oncology (Poznań, Poland), 2008-10, Vol.12 (6), p.272
issn 1428-2526
1897-4309
language eng ; pol
recordid cdi_proquest_journals_1237574428
source ProQuest - Publicly Available Content Database
title The role of radiation therapy in patients with primary and metastatic liver tumours
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T14%3A05%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20radiation%20therapy%20in%20patients%20with%20primary%20and%20metastatic%20liver%20tumours&rft.jtitle=Contemporary%20oncology%20(Poznan%CC%81,%20Poland)&rft.au=Glinski,%20Bogdan&rft.date=2008-10-01&rft.volume=12&rft.issue=6&rft.spage=272&rft.pages=272-&rft.issn=1428-2526&rft.eissn=1897-4309&rft_id=info:doi/&rft_dat=%3Cproquest%3E2839815241%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p113t-9e80b2dc346853091ad259c2e15d15ad2d5c218a583046a4b99b25f29ddb0da43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1237574428&rft_id=info:pmid/&rfr_iscdi=true